Cure My Disease

Don't miss your cure!

 Log in / Sign up

New combo therapy aims to shrink tough esophageal tumors

NCT ID NCT06531434

Recruiting now Disease control Sponsor: National Cheng-Kung University Hospital Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 34 times

Summary

This study tests a new treatment for T4 esophageal cancer, where the tumor has spread to nearby organs. Participants first receive chemotherapy for several cycles, then chemoradiation if the tumor shrinks enough. Researchers want to see if this approach improves response rates and survival while lowering the risk of a hole in the esophagus. About 22 adults aged 18-70 with this specific cancer type will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER TNM STAGING PRIMARY TUMOR (T) T4 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Cheng Kung University Hospital

    RECRUITING

    Tainan, Taiwan, 704302, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ESOPHAGEAL CANCER TNM STAGING PRIMARY TUMOR (T) T4 ESOPHAGEAL CANCER TNM STAGING PRIMARY TUMOR (T) T4